Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Biomolecules|January 28, 2026
Development of Mitochondria-Targeted PARP InhibitorsPavels Dimitrijevs, Marina Makrecka-Kuka, Pavel Arsenyan
Pharmaceutics|December 23, 2022
Olaparib Conjugates with Selenopheno[3,2-c]quinolinone Inhibit PARP1 and Reverse ABCB1-Related Multidrug ResistanceMarina Makrecka-Kuka, Jelena Vasiljeva, Pavels Dimitrijevs, et al.
Free Radical Biology & Medicine|January 23, 2021
Energy substrate metabolism and mitochondrial oxidative stress in cardiac ischemia/reperfusion injuryMaija Dambrova, Coert J Zuurbier, Vilmante Borutaite, et al.
European Journal of Medicinal Chemistry|May 22, 2023
Development of isoselenazolium chlorides as selective pyruvate kinase isoform M2 inhibitorsPavels Dimitrijevs, Marina Makrecka-Kuka, Agnieszka Bogucka, et al.
Pharmacological Research|February 7, 2016
Pharmacological effects of meldonium: Biochemical mechanisms and biomarkers of cardiometabolic activityMaija Dambrova, Marina Makrecka-Kuka, Reinis Vilskersts, et al.
Scientific Reports|December 10, 2020
Fused isoselenazolium salts suppress breast cancer cell growth by dramatic increase in pyruvate-dependent mitochondrial ROS productionMarina Makrecka-Kuka, Pavels Dimitrijevs, Ilona Domracheva, et al.
Basic & Clinical Pharmacology & Toxicology|March 1, 2017
Decrease in Long-Chain Acylcarnitine Tissue Content Determines the Duration of and Correlates with the Cardioprotective Effect of Methyl-GBBJanis Kuka, Marina Makrecka-Kuka, Helena Cirule, et al.
Frontiers in Cell and Developmental Biology|February 1, 2021
Microbiota-Derived Metabolite Trimethylamine N-Oxide Protects Mitochondrial Energy Metabolism and Cardiac Functionality in a Rat Model of Right Ventricle Heart FailureMelita Videja, Reinis Vilskersts, Stanislava Korzh, et al.
Pageof 5